Tirzepatide (Compounded) — Weight Loss prescription peptide by Biohaus
Featured

Certificate of Analysis

HPLC verified · Batch #2FF08C

Weight Loss

Tirzepatide (Compounded)

2.5mg-15mg weekly, titrated by physician

Compounded tirzepatide is a dual GIP and GLP-1 receptor agonist that represents the next generation of weight management therapy. Clinical studies show up to 22.5% body weight reduction. Our compounded version offers the same active compound at a fraction of branded cost, prepared under strict pharmaceutical standards.

Superior weight loss vs semaglutide
Dual pathway action
Improved insulin sensitivity
Reduced cardiovascular risk
Appetite control

Price

$399.00In Stock
HSA/FSA AcceptedUse your health savings account
Compounded under FDA 503A/503B exemptions. Not an FDA-approved product.
Compare with another peptide

Compounded tirzepatide is a dual GIP and GLP-1 receptor agonist that represents the next generation of weight management therapy. Clinical studies show up to 22.5% body weight reduction. Our compounded version offers the same active compound at a fraction of branded cost, prepared under strict pharmaceutical standards.

How It Works

Dual GIP and GLP-1 receptor agonist providing enhanced weight loss through dual incretin pathways

Primary Applications

Advanced weight management, type 2 diabetes support

Important Information

This product requires a valid prescription from a licensed physician. Compounded peptides are prepared by licensed, FDA-registered compounding pharmacies under USP 797/795 standards. Compounded medications are not FDA-approved and have not been evaluated for safety, efficacy, or therapeutic equivalence. Individual results may vary. All peptide protocols require physician evaluation and ongoing medical supervision.

Tirzepatide (Compounded)

$399.00

Choose your region

Where are you located?

We operate two completely separate platforms — different doctors, pharmacies, products, and prices. Pick once and we'll remember.

You can switch regions anytime from the top nav.